Amit Goyal, MD

Amit Goyal (@AmitGoyalMD) is an interventional cardiology fellow at the Cleveland Clinic. He completed his medical school at the University of California, San Diego and went on to enjoy residency training in the Osler Program at Johns Hopkins, where he served as the Assistant Chief of Service of the Barker Firm. As ACS he founded Osler Grand Rounds, an interactive mystery case discussion, and helped establish a novel morning report structure integrating bedside skills education. He is looking forward to a career in interventional cardiology and medical education. He relishes time with friends and family including with his wife Riddhi and sons Dhruv, Aarav, and Atharv.

Articles by Amit Goyal, MD

Amit Goyal, MDInterventional Cardiology | January 22, 2025
The observational REDUCER-I study aims to evaluate the real-world safety and effectiveness of the coronary sinus reducer.
Read More
Amit Goyal, MDCardioNerds | January 17, 2025
Dr. Amit Goyal details a study which explored the role of coronary sinus reducer in Coronary microvascular dysfunction.
Amit Goyal, MDInterventional Cardiology | January 14, 2025
The possibility of DCBs to rescue side branches during provisional coronary bifurcation stenting is appealing.
Amit Goyal, MDCardioNerds | January 3, 2025
Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
A study highlights the significant HCRU and costs associated with ATTR-CM.
Amit Goyal, MDAHA 2024: CardioNerds | November 26, 2024
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
Amit Goyal, MDTCT 2024 | November 7, 2024
Results of the EARLY TAVR trial introduced a potential paradigm shift in managing asymptomatic high-gradient severe AS.
Amit Goyal, MDTCT 2024 | December 4, 2024
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
Amit Goyal, MDTCT 2024 | December 4, 2024
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
Amit Goyal, MDTCT 2024 | December 4, 2024
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
Amit Goyal, MDCardioNerds | September 26, 2024
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
Amit Goyal, MDCardioNerds | September 25, 2024
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
Amit Goyal, MDInterventional Cardiology | September 11, 2024
The SENIOR-RITA trial investigates the optimal management strategy for older adults with NSTEMI.
Amit Goyal, MDAtrial Fibrillation | September 10, 2024
The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD.
Amit Goyal, MDESC Congress 2024 | September 4, 2024
The SCOFF trial challenges the long-standing practice of fasting before cardiac catheterization procedures.
Amit Goyal, MDESC Congress 2024 | September 3, 2024
The NOTION 3 trial contributes important data to the ongoing debate about the role of PCI before TAVI in patients with CAD.
Amit Goyal, MDInterventional Cardiology | August 28, 2024
While transvenous pacemakers have been the standard, the emergence of leadless pacemakers offers a promising alternative,
Amit Goyal, MDCardioNerds | August 14, 2024
Dr. Amit Goyal details the bRIGHT study, which offers a valuable glimpse into the performance of the Abbott TriClip device.
Amit Goyal, MDCardioNerds | October 17, 2024
Treatment-related early increase in serum transthyretin levels are associated with reduced CV-related hospitalizations.
Amit Goyal, MDCardioNerds | October 17, 2024
A study uncovered surprising findings regarding the presence and nature of transthyretin in stenotic aortic valves.